Literature DB >> 8761239

Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.

N Saunders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8761239      PMCID： PMC2351782          DOI： 10.1136/bmj.313.7054.423a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Ecstasy and neurodegeneration.

Authors:  A R Green; G M Goodwin
Journal:  BMJ       Date:  1996-06-15

2.  5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.

Authors:  M I Colado; T K Murray; A R Green
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Authors:  J M Wilson; K S Kalasinsky; A I Levey; C Bergeron; G Reiber; R M Anthony; G A Schmunk; K Shannak; J W Haycock; S J Kish
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

4.  Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

Authors:  P K McGuire; H Cope; T A Fahy
Journal:  Br J Psychiatry       Date:  1994-09       Impact factor: 9.319
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.